Establishment of a Subsidiary Specialising in Testing Services
First written in FY2022-Q2. 1 of 3 entries say "Achieved", first in FY2022-Q3. Latest entry: FY2024-Q2.
No other company in this theme has enough history to compare yet.
- FY2024-Q2DroppedAnnual report
「At a meeting of the Board of Directors held on 23 April 2024, the company resolved to dissolve and liquidate its consolidated subsidiary 株式会社ワン・サイエンス.」
Following its establishment, the wholly owned subsidiary ワン・サイエンス, which specialized in testing services, was resolved to be dissolved and liquidated, and further development of the business was abandoned. - FY2022-Q3AchievedAnnual report
「On 18 May 2022, the company established its consolidated subsidiary 株式会社ワン・サイエンス (Healthcare Solutions Business), resulting in the company group comprising the company, its consolidated subsidiary 株式会社ワン・サイエンス, and 3 equity-method affiliates.」
The establishment of the wholly owned subsidiary ワン・サイエンス, specializing in contract dementia testing, PCR testing and clinical testing, was completed on 18 May 2022, and it became a consolidated subsidiary from the third quarter. - FY2022-Q2First statedAnnual report
「As improving the accuracy of testing technologies and increasing operational efficiency become essential to capture more of this demand, the company decided to establish a subsidiary specializing in testing services in order to deploy its management resources more efficiently and strengthen the business foundation. Company name: ワン・サイエンス. Business: Contract testing services for dementia testing, PCR testing and clinical testing. Capital: ¥20 million. Expected date of establishment: 18 May 2022. Ownership: the company, 100%.」
The company decided to establish a wholly owned subsidiary specializing in contract dementia testing, PCR testing and clinical testing. The subsidiary will have capital of ¥20 million and is scheduled to be established on 18 May 2022, with consolidation scheduled to begin in the third quarter of the fiscal year ending September 2022.